Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance Cover

.blurhash-client-img { display: none !important; }

Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance

Forum of Clinical Oncology

Volume 12 (2021): Issue 3 (December 2021)

By: E. Karamitrousis, I. Balgkouranidou, N. Xenidis, K. Amarantidis, E. Biziota, T. Koukaki and S. Kakolyris

Open Access

|May 2022

Figures & Tables

Correlation of cfDNA concentration with OS in patients with metastatic gastric cancer.

Correlation of cfDNA concentration with PFS in patients with metastatic gastric cancer.

Clinicopathological characteristics of the patients_

Patient characteristics	n (70)

Gender
Females	27
Males	43
Age
≤ 60 years	19
> 60 years	51
Tumour differentiation
Intermediate	27
Poor	26
Good	17
Histology
Intestinal	32
Diffuse	23
Other	15

DOI: https://doi.org/10.2478/fco-2021-0010 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X

Journal RSS Feed

Language: English

Page range: 72 - 76

Submitted on: Oct 14, 2021

|

Accepted on: Dec 23, 2021

|

Published on: May 7, 2022

Published by: Helenic Society of Medical Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

gastric cancer,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology

© 2022 E. Karamitrousis, I. Balgkouranidou, N. Xenidis, K. Amarantidis, E. Biziota, T. Koukaki, S. Kakolyris, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 12 (2021): Issue 3 (December 2021)Next article